Journal Club #1 - The CRASH-3 Trial with Professor Ian Roberts

Thank you to Prof. Ian Roberts for speaking to us about the CRASH-3 trial, which evaluated the effect of tranexamic acid on mortality and disability in patients with traumatic brain injury (TBI).
This was NANSIG's inaugural journal club - we thank you for tuning in live or through this catch-up format, and hope you'll join us for more discussions!
Please like and subscribe to our channel for more content. Thank you!